Legal Representation
Attorney
JANET G RICCIUTI
USPTO Deadlines
Next Deadline
2124 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-06)
Due Date
May 06, 2031
Grace Period Ends
November 06, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description |
|---|---|---|---|
| May 6, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| May 6, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Mar 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Mar 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Feb 25, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 25, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 25, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 25, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 15, 2025 | RFNT | P | REFUSAL PROCESSED BY IB |
| Jan 30, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Jan 30, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Dec 28, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Dec 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 27, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Oct 9, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Oct 9, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 3, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 001
Chemicals for use in the manufacture of human pharmaceutical and vaccine products and veterinary pharmaceutical and vaccine products; Plant extracts, active ingredients and excipients, other than essential oils, used in the manufacture of human pharmaceutical and vaccine products and veterinary pharmaceutical and vaccine products; Antibodies used in the manufacture of active vaccine ingredients
Class 005
Pharmaceutical products, namely, pharmaceutical preparations for the diagnosis, the prevention, the monitoring and the treatment of cancers, community and hospital-acquired infections, chronic respiratory diseases, wounds healing; Pharmaceutical products, namely, antibodies and monoclonal antibodies for medical purposes; Veterinary products, namely, veterinary pharmaceutical preparations for the diagnosis, the prevention, the monitoring and the treatment of cancers, community and hospital-acquired infections, chronic respiratory diseases, wounds healing; Vaccines for human use; Vaccines for veterinary use
Class 042
Medical research services; scientific research for medical purposes; Research and development of vaccines and medicines
Additional Information
Translation
The wording ALPIONER has no meaning in a foreign language.
Classification
International Classes
001
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
THERAPEUTICS